Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Genome Therapeutics and ArQule begin high-throughput screening

Oct. 5, 1998

Novavax presents BCTP, a novel antimicrobial nanoemulsion, at ICAAC

Oct. 2, 1998

L-084 selected for further development as oral carbapenem prodrug

Oct. 2, 1998

Pfizer presents a new macrolide that retains good activity in macrolide-resistant strains

Oct. 2, 1998

New echinocandin antifungal discovered by Fujisawa profiled up to phase I at ICAAC

Oct. 2, 1998

Inhibitors of bacterial protein identified at Cubist

Oct. 2, 1998

Xoma presents recombinant variant of rBPI21 with potent antiinfective activity

Oct. 2, 1998

Cubist and Novalon identify small-molecule inhibitors of bacterial enzyme

Oct. 2, 1998

Abbott uses TE-802 as lead to develop broader spectrum ketolides

Oct. 2, 1998

Voriconazole, a promising treatment for serious fungal infections

Oct. 2, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...